FMD2 clinical trials at UCSD
2 in progress, 1 open to eligible people
Showing trials for
AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
open to eligible people ages 16-70
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
San Diego, California and other locations
AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, accepting new patients by invitation only
A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, and Pharmacokinetics of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
San Diego, California and other locations
Last updated: